Benefit of folic acid supplementation in parkinsonian patients treated with levodopa.
Müller
T
T
Woitalla
D
D
Kuhn
W
W
D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005492:Folic Acid / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D006397:Hematinics / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D018570:Risk Assessment
D000978:Antiparkinson Agents; D006397:Hematinics; D007980:Levodopa; D005492:Folic Acid